BioInfra Statistics

Total Valuation

BioInfra has a market cap or net worth of KRW 23.28 billion. The enterprise value is 26.40 billion.

Market Cap	23.28B
Enterprise Value	26.40B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	Dec 29, 2025

Share Statistics

BioInfra has 4.86 million shares outstanding. The number of shares has increased by 0.43% in one year.

Current Share Class	4.86M
Shares Outstanding	4.86M
Shares Change (YoY)	+0.43%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	51.53%
Owned by Institutions (%)	n/a
Float	2.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.06
PB Ratio	1.16
P/TBV Ratio	1.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.69
EV / Sales	1.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.26

Financial Position

The company has a current ratio of 0.70, with a Debt / Equity ratio of 0.54.

Current Ratio	0.70
Quick Ratio	0.62
Debt / Equity	0.54
Debt / EBITDA	n/a
Debt / FCF	-5.02
Interest Coverage	-17.35

Financial Efficiency

Return on equity (ROE) is -23.46% and return on invested capital (ROIC) is -12.09%.

Return on Equity (ROE)	-23.46%
Return on Assets (ROA)	-10.73%
Return on Invested Capital (ROIC)	-12.09%
Return on Capital Employed (ROCE)	-32.25%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.58
Inventory Turnover	n/a

Taxes

Income Tax	-1.73B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.07% in the last 52 weeks. The beta is 0.67, so BioInfra's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	-30.07%
50-Day Moving Average	4,810.70
200-Day Moving Average	5,493.03
Relative Strength Index (RSI)	54.39
Average Volume (20 Days)	14,532

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioInfra had revenue of KRW 21.92 billion and -5.63 billion in losses. Loss per share was -1,157.12.

Revenue	21.92B
Gross Profit	4.87B
Operating Income	-6.53B
Pretax Income	-7.35B
Net Income	-5.63B
EBITDA	-3.13B
EBIT	-6.53B
Loss Per Share	-1,157.12

Full Income Statement

Balance Sheet

The company has 7.68 billion in cash and 10.81 billion in debt, giving a net cash position of -3.13 billion or -642.92 per share.

Cash & Cash Equivalents	7.68B
Total Debt	10.81B
Net Cash	-3.13B
Net Cash Per Share	-642.92
Equity (Book Value)	20.08B
Book Value Per Share	4,127.23
Working Capital	-4.92B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.04 billion and capital expenditures -1.11 billion, giving a free cash flow of -2.15 billion.

Operating Cash Flow	-1.04B
Capital Expenditures	-1.11B
Free Cash Flow	-2.15B
FCF Per Share	-442.67

Full Cash Flow Statement

Margins

Gross margin is 22.23%, with operating and profit margins of -29.80% and -25.67%.

Gross Margin	22.23%
Operating Margin	-29.80%
Pretax Margin	-33.55%
Profit Margin	-25.67%
EBITDA Margin	-14.29%
EBIT Margin	-29.80%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 400.00, which amounts to a dividend yield of 8.58%.

Dividend Per Share	400.00
Dividend Yield	8.58%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.43%
Shareholder Yield	8.15%
Earnings Yield	-24.18%
FCF Yield	-9.25%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioInfra has an Altman Z-Score of 1.04 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.04
Piotroski F-Score	1